The medical technology company Invent Medic reports decreased revenue in the fourth quarter compared with the same period the year before. The net loss decreased.Revenue fell 14.3 percent to SEK 1.8 million (2.1).Gross profit was SEK 1.4 million (1.6), with a gross margin of 77.8 percent (76.2). Result before and after tax was -SEK 1.1 million (-2.5). Cash flow from operating activities amounted to -SEK 0.3 million (-3.6). Cash and cash equivalents amounted to SEK 0.50 million (1.25)."As I now look back at 2025, I see a year that has largely been about building, often behind the scenes. The goal has been clear: to create an Invent Medic that is well positioned for profitable growth. Full-year sales are slightly higher compared with the previous year while margins have improved significantly – a clear confirmation that the priorities we have made during the year were right", writes CEO Gunilla Nilsson. Invent Medic, SEK millionQ4-2025Q4-2024ChangeNet sales1.82.1-14.3%Gross profit1.41.6-12.5%Gross margin77.8%76.2%Result before tax-1.1-2.5Net result-1.1-2.5Cash flow from operating activities-0.3-3.6Cash and cash equivalents0.501.25-60.0%